PledPharma announced that Christian Sonesson has been appointed to the newly created position as Vice President Product Strategy and Development. He will lead the continued development program of the company's drug candidate PledOx ®, as well as being responsible for the design of pricing strategies, initial market positioning and expansion of potential indications. He has been 13 years at AstraZeneca and most recently as Director Global Products, where he was responsible for overall project strategies and the delivery of comprehensive Phase III clinical trials. Christian also has extensive experience of interactions with regulatory authorities and from successful registrations of new drug candidates in different regions. Christian is joining PledPharma on August 15, 2017.